当前位置：药药网 / 数据中心 / 儿科研究特征电子表格
Actemra
儿科标签批准日期
2018/9/12 0:00:00
特定指示/秒
Systemic juvenile idiopathic arthritis in pediatric patients 2 through 17 years – Subcutaneous
标签更改摘要
- Approved new subcutaneous dosing and administration for the active systemic juvenile idiopathic arthritis in patients 2 years of age and older.
- Information on dosing, clinical trials
- Postmarketing study.
研究年龄
2 YEARS - 17 YEARS
1 YEARS - 17 YEARS
学习类型
Efficacy,Safety
Safety,Pharmacokinetic,Pharmacodynamic
研究设计
Multicenter,Randomized,Double-Blind,placebo-controlled,parallel -group
Multicenter,Open-label